Periganglionic Resiniferatoxin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Periganglionic Resiniferatoxin, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain [Phase 1, Phase 2]